Detection of Nonalcoholic Fatty Liver Disease | DMSO - Dove Medical Press
6/21/2022 12:00:00 AM2 years 10 months ago
by Dove Press
by Dove Press
Addressing the value of circulating miRNA-122 and serum pro-neurotensin as a potential non-invasive biomarker for diagnosing non-alcoholic fatty acid diseases
Introduction Nonalcoholic fatty liver disease (NAFLD) is considered one of the health problems with great burden on the liver that may end with liver cirrhosis and hepatocellular carcinoma.1 Univers… [+26017 chars]
full article...